Management of CLL patients in the front-line setting: live broadcast

Published: 19 Apr 2016

Rating:

Save

Dr Catherine Hood, Dr Robin Foà, Dr Patrick Thornton, and Prof Stephan Stilgenbauer

Watch an expert panel debate the latest treatments for chronic lymphocytic leukaemia.

Live on the 13th April at 17:00-18:00 CEST

Dr Catherine Hood (UK), Dr Robin Foà (Italy), Dr Patrick Thornton (UK) and Prof Stephan Stilgenbauer (Germany) debate management of CLL patients in the front-line setting, with interactive polling.

After participating in this broadcast you should be able to discuss management strategies for patients with CLL in the front-line setting.

This programme has been supported by an unrestricted educational grant from Janssen Pharmaceutica (A Johnson & Johnson Company).

Related Videos

Made to measure: Choosing the optimal regimen in transplant-eligible NDMM

Dr Elias Mai - Heidelberg University, Heidelberg, Germany

28 Oct 2024

Guiding transplant decisions in multiple myeloma with MRD

Dr Susan Bal - University of Alabama at Birmingham, Birmingham, USA

28 Oct 2024

Revolutionising multiple myeloma treatment with CAR T-Cell therapies

Dr Susan Bal - University of Alabama at Birmingham, Birmingham, USA

28 Oct 2024

Isa-KRd quad regimen in NDMM: MIDAS and CONCEPT studies

Prof Philippe Moreau - University Hospital of Nantes, Nantes, France

30 Sep 2024

Glofit-GemOx shows clinically meaningful benefit in relapsed/refractory diffuse large B-cell lymphoma

Dr Jeremy Abramson - Mass General Cancer Center, Boston, USA

$Glofit-GemOx shows clinically meaningful benefit in relapsed/refractory diffuse large B-cell lymphoma ( Dr Jeremy Abramson - Mass General Cancer Center, Boston, USA )$